ADALIE RAYMIS-DURAN: Open Payments
NPI 1669923728 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,402 in 124 payments from 17 companies in 2025. Trend: 2023 $471 · 2024 $2,950 · 2025 $2,402
Food & beverage: $2,169Education: $233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $705 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $295 |
| Arcutis Biotherapeutics, Inc. | 22 | $229 |
| Janssen Biotech, Inc. | 7 | $186 |
| UCB, Inc. | 7 | $157 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| Incyte Corporation | 6 | $121 |
| GENZYME CORPORATION | 4 | $105 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $83 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $79 |
Products named: SKYRIZI, Zoryve, DUPIXENT, TREMFYA, BOTOX, ILUMYA, Bimzelx, OPZELURA.
Industry payments across TX — which companies pay providers there.
